InvestorsHub Logo
Followers 1
Posts 123
Boards Moderated 0
Alias Born 03/15/2019

Re: XenaLives post# 190108

Sunday, 04/21/2019 2:49:51 PM

Sunday, April 21, 2019 2:49:51 PM

Post# of 463735
Like I wrote in other post, nothing new/ important except two points.
- Only Pdd trial In Europe.
- No improvements in last 15 years.
- He explained the trial..trial with placebo.., first step 2 weeks of screening ,14 weeks taking the drug/placebo, nobody knows what the patient is taking..
-He explained Pd/ pdd , ..main problem quality of life.., he mentioned that one of the symptoms associated to Pd is that it affects to sleep.
- Only in Spain about 300 k patients with Pd. He also said that Anavex chose Spain but he didn´t say the reason, but he said that Spain is a top country in the world in investigation.
-Full enrollment for screening he estimated probably by May, first step two weeks of screening, 150 patients for screening. They use test moca( between 13- 23 points) . Main problem for patients that are finally not include is lack of vitamine b12.
- If they get + results, next step a phase 3 with more patients.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News